HIV / AIDS in the News

Letters: CDC cuts imperil S.F.’s ongoing quest to achieve ‘Zero HIV’ - San Francisco Chronicle

 

US court rules HIV-positive people can be banned from military - PinkNews

 

Why Liver Pressure Can Persist After HCV Cure, Especially With HIV - European Medical Journal

 

Kenya To Roll Out Breakthrough HIV Prevention Drug In March - Arise News

 

Destigmatizing HIV Spoken Words - Trend Hunter

 

Cancer and HIV Vaccines Enter the Therapeutic Era - Medscape

 

New gene-editing method cuts HIV DNA from infected cells across strains - The South First

 

Injectable HIV Regimen Cuts Failure Risk in Nonadherent Populations - Medical Professionals Reference

 

U.S. Department of Defense can keep HIV enlistment ban, appeals court rules - cbs8.com

 

ViiV, GSK detail monthly HIV treatment's success over daily tablets - firstwordpharma.com

 

4th Circuit rules against discharged service members with HIV - Washington Blade

 

4th Circ. Backs Military Policy Banning HIV-Positive Enlistees - Law360

 

4th Circ. Backs Military Policy Banning HIV-Positive Enlistees - Law360

 

Exposing a hidden anchor for HIV replication - Phys.org

 

GSK's HIV Treatment Achieves Superior Results in Phase III Trial - GuruFocus

 

Georgia bill would allow pharmacists to prescribe PrEP in effort to expand HIV prevention access - CBS News

 

Fourth Circuit defers to military on policy disqualifying HIV-positive applicants - Courthouse News

 

Fourth Circuit defers to military on policy disqualifying HIV-positive applicants - Courthouse News

 

Pentagon can ban recruits living with HIV, conservative court rules - The Independent

 

Pentagon can ban recruits living with HIV, conservative court rules - the-independent.com

 

ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM - Yahoo Finance

 

Monthly HIV shots outperform daily pills for people with adherence challenges - Stock Titan

 

ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM - Business Wire

 

HIV assistance cuts: Is the DeSantis administration ‘kneecapping’ Legislature? - Florida Phoenix

 

Fourth Circuit Reinstates Military’s HIV Ban - Lambda Legal

 

ViiV Healthcare to share pipeline and real-world data at CROI 2026 - Managed Healthcare Executive

 

US military's ban on enlistment by people with HIV upheld by appeals court - Reuters

 

US military's ban on enlistment by people with HIV upheld by appeals court - TradingView

 

Military Can Enforce Policy Banning HIV-Positive Enlistees, 4th Circuit Rules - Law.com

 

Revealing a Concealed Key to HIV Replication - Bioengineer.org